Skip to Main Content

Author Details

Manoela Tiago
Thomas Jefferson University
2011
23
12
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37444561Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.Cancers (Basel)2023
35296667Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.Nat Commun2022
35657206A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.Cancer Res2022
36044013Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma.Mol Cancer Res2022
35046531Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.Oncogene2022
34389658Correction: Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma.Clin Cancer Res2021
33568347Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i>-Driven Uveal Melanoma.Clin Cancer Res2021
34879275SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.Cell Rep2021
32535222Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.Pharmacol Res2020
31932756Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma.Br J Cancer2020
32661093Activation of CD8<sup>+</sup> T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors.Cancer Immunol Res2020
30911007CADM1 is a TWIST1-regulated suppressor of invasion and survival.Cell Death Dis2019
31063649The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.Pigment Cell Melanoma Res2019
30703359BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.J Invest Dermatol2019
29649428Connections of annexin A1 and translocator protein-18⿯kDa on toll like receptor stimulated BV-2 cells.Exp Cell Res2018
27829164Molecular effects of 1-naphthyl-methylcarbamate and solar radiation exposures on human melanocytes.Toxicol In Vitro2017
27436149Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.Pharmacol Res2016
24657526Basic Red 51, a permitted semi-permanent hair dye, is cytotoxic to human skin cells: Studies in monolayer and 3D skin model using human keratinocytes (HaCaT).Toxicol Lett2014
24788523A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies.PLoS One2014
24548268Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.Tissue Eng Part A2014
23527236Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy.PLoS One2013
22372875Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death.Pigment Cell Melanoma Res2012
21029393Artificial skin in perspective: concepts and applications.Pigment Cell Melanoma Res2011
  • 1 - 23 of 23

Recommended Authors

Kerrie L Marie
The University of Manchester
Career Start Year 2015
Number of shared co-authors 4
Giuseppina Claps
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year 2010
Number of shared co-authors 3
Eva P??rez-Guijarro
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 2009
Number of shared co-authors 4
Steven E Robinson
University of Colorado Anschutz Medical Campus
Career Start Year 2008
Number of shared co-authors 3
Michael P O'Connell
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 2
Jesse M Zaretsky
University of California los angeles
Career Start Year 2007
Number of shared co-authors 0
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 7
M Raza Zaidi
Northwell Health Cancer Institute
Career Start Year 2006
Number of shared co-authors 4
Shadmehr Demehri
Massachusetts General Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 3
Hussein A Tawbi
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 5
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 4
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 4
Beate Rinner
Medical University of Graz
Career Start Year 2000
Number of shared co-authors 1
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Career Start Year 1999
Number of shared co-authors 1
Yardena Samuels
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 9
Cindy Sander
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Richard W Joseph
Mayo Clinic Hospital
Career Start Year 1994
Number of shared co-authors 2
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 7
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 7
Rene Gonzalez
University of Colorado Anschutz Medical Campus
Career Start Year 1990
Number of shared co-authors 4
Craig L Slingluff
University of Virginia
Career Start Year 1987
Number of shared co-authors 2
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
Grant A McArthur
University of Melbourne
Career Start Year 1986
Number of shared co-authors 7
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Career Start Year 1985
Number of shared co-authors 8
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 5
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 2
John M Kirkwood
UPMC Hillman Cancer Center
Career Start Year 1974
Number of shared co-authors 6
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 7

Collaborators

Andrew E Aplin
Thomas Jefferson University
Co-authored papers 13
Takami Sato
Sidney Kimmel Cancer Center, Thomas Jefferson University
Co-authored papers 3
Gaurav Kumar
Gladstone Institutes
Co-authored papers 2
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Robert Saddawi-Konefka
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Ayush Kishore
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Simone Lubrano
Moores Cancer Center, University of California
Co-authored papers 2
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Silvia Coma
Boston Children's Hospital and Dana-Farber Cancer Institute
Co-authored papers 2
Jonathan A Pachter
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Co-authored papers 2
Kyle Ford
University of California San Diego
Co-authored papers 2
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers 2
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Justine S Paradis
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Xingyu Wu
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Frederico Gomes
Co-authored papers 1
Reinhard Dummer
University Hospital Zurich
Co-authored papers 1
Monica Acosta
Co-authored papers 1
Monica Acosta
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 1
Rui Manuel Reis
Co-authored papers 1
Danielle Palma de Oliveira
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Co-authored papers 1
Richard S Paules
Co-authored papers 1
Phil F Cheng
University Hospital of Zurich
Co-authored papers 1
David W Speicher
Co-authored papers 1
Mitchell P Levesque
University Hospital Zurich
Co-authored papers 1
Laura Beatriz da Silva Cardeal
Chemistry Institute, University of Sao Paulo
Co-authored papers 1
Frederico Gomes
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Release 1.2